A large registry study in young people with type 1 diabetes found that hybrid closed-loop systems were linked to slightly better HbA1c and more time in the target glucose range than open-loop pump ...
Portal Diabetes announced today that it received FDA breakthrough device designation for its implantable insulin pump system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results